Multiple Myeloma Case Developed During the Use of the Teriparatide

Multiple Myeloma Case Developed During the Use of the Teriparatide

Recombinant human parathyroid hormone (1-34) (rhPTH 1-34), teriparatide, is a class of anabolic therapy for treating severe osteoporosis. Although plasma cell dyscrasias are excluded among the known side effects of teriparatide treatment, their association in the form of case reports has been report...

Full description

Saved in:
Bibliographic Details
Main Authors: Zehra Erdemir, Ayşe İyiyapıcı Ünübol, Mustafa Ünübol, Esra Ercan Aktekin, İrfan Yavaşoğlu, Engin Güney
Format: Article
Language:English
Published: Galenos Publishing House 2022-04-01
Series:Türk Osteoporoz Dergisi
Subjects:
osteoporosis
teriparatide
multiple myeloma
Online Access: http://www.turkosteoporozdergisi.org/archives/archive-detail/article-preview/multiple-myeloma-case-developed-during-the-use-of-/51345
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.turkosteoporozdergisi.org/archives/archive-detail/article-preview/multiple-myeloma-case-developed-during-the-use-of-/51345

Similar Items